Literature DB >> 26190538

Frequency of isolated maternal hypothyroxinemia in women with gestational diabetes mellitus in a moderately iodine-deficient area.

Ayten Oguz1, Dilek Tuzun1, Murat Sahin1, Alper Celil Usluogullari2, Betül Usluogullari3, Ahmet Celik4, Kamile Gul1.   

Abstract

AIM: To investigate frequency of isolated maternal hypothyroxinemia (IMH) in women with gestational diabetes mellitus (GDM) using both the method specific trimester range (MSTR) and the standard reference range (SRR).
METHODS: Our study included 50 GDM patients (case group) and 60 non-GDM pregnant (control group). Glucose, insulin, HOMA-IR, fT4 and TSH values were measured when pregnancy was confirmed in all participants. Thyroid function tests were measured in each trimester using the SRR and the MSTR.
RESULTS: In the second and third trimesters, mean fT4 levels were significantly lower in the case group compared to the control group, based on the SRR (p < 0.001). Mean fT4 levels were within the normal reference range in both groups, based on the MSTR; however, the levels were significantly lower in the case group (p < 0.001). Using the SRR, IMH frequencies in the second and third trimesters, in the case group were 56 and 86%, respectively, and were 13.3 and 46.7%, respectively, in the control group (p < 0.001). Using the MSTR, the IMH frequencies in the second and third trimesters were 8 and 14%, respectively; there were no instances of IMH in the control group.
CONCLUSION: This study shows that changes in glucose metabolism may affect the thyroid hormone levels (fT4). Additionally, evaluating thyroid function tests in GDM patients using the MSTR can give more accurate results.

Entities:  

Keywords:  Gestational diabetes mellitus; isolated maternal hypothyroxinemia; thyroid peroxidase antibody

Mesh:

Substances:

Year:  2015        PMID: 26190538     DOI: 10.3109/09513590.2015.1054801

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  6 in total

1.  A Longitudinal Study of Thyroid Markers Across Pregnancy and the Risk of Gestational Diabetes.

Authors:  Shristi Rawal; Michael Y Tsai; Stefanie N Hinkle; Yeyi Zhu; Wei Bao; Yuan Lin; Pranati Panuganti; Paul S Albert; Ronald C W Ma; Cuilin Zhang
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

2.  Maternal Thyroid Function During Pregnancy or Neonatal Thyroid Function and Attention Deficit Hyperactivity Disorder: A Systematic Review.

Authors:  Samantha S M Drover; Gro D Villanger; Heidi Aase; Thea S Skogheim; Matthew P Longnecker; R Thomas Zoeller; Ted Reichborn-Kjennerud; Gun P Knudsen; Pål Zeiner; Stephanie M Engel
Journal:  Epidemiology       Date:  2019-01       Impact factor: 4.822

3.  Free Thyroxine During Early Pregnancy and Risk for Gestational Diabetes.

Authors:  James E Haddow; Wendy Y Craig; Louis M Neveux; Glenn E Palomaki; Geralyn Lambert-Messerlian; Fergal D Malone; Mary E D'Alton
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

4.  Association between isolated hypothyroxinaemia in early pregnancy and perinatal outcomes.

Authors:  Xiujuan Su; Yan Zhao; Zhijuan Cao; Yingying Yang; Tony Duan; Jing Hua
Journal:  Endocr Connect       Date:  2019-04       Impact factor: 3.335

5.  Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin.

Authors:  Anastasia Trouva; Michael Alvarsson; Jan Calissendorff; Bjørn Olav Åsvold; Eszter Vanky; Angelica Lindén Hirschberg
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-21       Impact factor: 5.555

6.  A longitudinal study of thyroid markers during pregnancy and the risk of gestational diabetes mellitus and post-partum glucose metabolism.

Authors:  Lei Tang; Ping Li; Hua Zhou; Ling Li
Journal:  Diabetes Metab Res Rev       Date:  2021-02-22       Impact factor: 4.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.